Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals    VRTX

VERTEX PHARMACEUTICALS

(VRTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on VERTEX PHARMACEUTICALS
04/29/21 Q1 2021 Earnings Release (Projected)
07/28/21 Interim 2021 Earnings Release (Projected)
10/27/21 Q3 2021 Earnings Release (Projected)
02/02/22 FY 2021 Earnings Release (Projected)
Past events on VERTEX PHARMACEUTICALS
02/01/21 | 04:30pm FY 2020 Earnings Call
02/01/21 | 04:01pm FY 2020 Earnings Release
01/11/21 | 09:10am JP Morgan Healthcare Conference
12/09/20 | 08:00am CTX001™ Phase 1/2 Study Results Call
Upcoming sector events for VERTEX PHARMACEUTICALS
03/01/21 BIO-TECHNE CORPORATION : Advances in Genome Biology and Technology Exhibition
03/01/21 | 02:00pm ULTRAGENYX PHARMACEUTICAL INC. : Cowen Health Care Conference
03/01/21 | 04:30pm NOVAVAX, INC. : FY 2020 Earnings Call
03/01/21 | 04:30pm TURNING POINT THERAPEUTICS, INC. : FY 2020 Earnings Call
More events
Past sector events for VERTEX PHARMACEUTICALS
02/27/21 | 05:10pm REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Abstract #461A
02/26/21 | 01:00pm EXELIXIS, INC. : SVB Leerink Global Healthcare Conference
02/26/21 | 11:20am IONIS PHARMACEUTICALS, INC. : SVB Leerink Global Healthcare Conference
02/26/21 | 10:40am ACADIA PHARMACEUTICALS INC. : SVB Leerink Global Healthcare Conference
Annual publications
Annual results201620172018201920202021 (e)
Sales
M $
Released
Forecast
Spread
1 702
1 696
0,38%
2 489
2 431
2,4%
3 048
2 992
1,9%
4 163
3 759
11%
6 206
6 159
0,76%

6 947
Operating income
(EBITDA)
M $
Released
Forecast
Spread
71,3
58,7
22%
185
119
56%
1 184
1 123
5,4%
1 893
1 770
6,9%
3 601
3 649
-1,3%

4 190
Operating profit
(EBIT)
M $
Released
Forecast
Spread
288
278
3,8%
564
538
4,9%
1 112
1 052
5,7%
1 786
1 609
11%
3 491
3 471
0,58%

3 846
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-67,4
-91,9
27%
-15,7
-70,5
78%
600
771
-22%
1 395
964
45%
3 117
2 891
7,8%

3 152
Net income
M $
Released
Forecast
Spread
-112
-135
17%
263
237
11%
2 097
740
183%
1 177
796
48%
2 712
2 608
4,0%

2 558
EPS
$
Released
Forecast
Spread
-0,46
-0,55
17%
1,04
0,90
15%
8,09
2,84
185%
4,51
3,08
46%
10,3
9,87
4,2%

9,86
Announcement Date01/25/201701/31/201802/05/201901/30/202002/01/2021

Quarterly publications
Previous periodNext period
Quarterly results2019 Q42020 Q12020 Q22020 Q32020 Q42021 Q1 (e)
Sales
M $
Released
Forecast
Spread
1 413
1 013
40%
1 515
1 287
18%
1 524
1 393
9,4%
1 538
1 480
3,9%
1 628
1 585
2,7%

1 658
Operating income
(EBITDA)
M $
Released
Forecast
Spread
619
483
28%
747
759
-1,6%
901
875
2,9%
881
890
-1,1%
916
1 001
-8,5%

1 030
Operating profit
(EBIT)
M $
Released
Forecast
Spread
593
429
38%
877
628
40%
874
725
21%
854
797
7,2%
887
872
1,7%

920
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
677
237
185%
658
531
24%
825
569
45%
746
658
13%
889
704
26%

760
Net income
M $
Released
Forecast
Spread
583
189
208%
603
408
48%
837
433
93%
667
523
28%
604
577
4,8%

620
EPS
$
Released
Forecast
Spread
2,23
0,76
194%
2,29
1,60
43%
3,18
1,66
91%
2,53
1,98
28%
2,30
2,13
8,2%

2,28
Announcement Date01/30/202004/29/202007/30/202010/29/202002/01/2021

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise